Notable difference was reported in serum ApoB/ApoA1 ratio between LC and HCC patients at different stages, and combined diagnosis with AFP exhibited the capability of increasing the detection efficacy and specificity of AFP for HCC and AFP-negative HCC. The gene discussed is APOA1; the disease is hepatocellular carcinoma.